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1. INTRODUCTION {#hbm24797-sec-0001}
===============

Schizophrenia is a serious mental disorder that imposes a significant burden on society around the world (Charlson, Baxter, Cheng, Shidhaye, & Whiteford, [2016](#hbm24797-bib-0012){ref-type="ref"}). The clinical symptoms of schizophrenia are heterogeneous (Arango & Carpenter, [2011](#hbm24797-bib-0005){ref-type="ref"}; Owen, [2014](#hbm24797-bib-0074){ref-type="ref"}), and its diagnosis is still dependent on the subjective report from patients and assessment by clinicians (Frances, [1994](#hbm24797-bib-0072){ref-type="ref"}).

With the aim to provide objective assessment to guide clinical practice, integrative psychobiological approaches including the Research Domain Criteria initiative (Kozak & Cuthbert, [2016](#hbm24797-bib-0037){ref-type="ref"}) and the Hierarchical Taxonomy of Psychopathology (Kotov et al., [2017](#hbm24797-bib-0036){ref-type="ref"}) suggest breaking the symptom‐oriented approach down to different levels of neuroscientific analysis for mental disorders. In line with these new approaches, patients with schizophrenia have been demonstrated to have functional and structural brain alterations from magnetic resonance imaging (MRI) research (Cheng, Newman, et al., [2015](#hbm24797-bib-0013){ref-type="ref"}; Cheng, Palaniyappan, et al., [2015](#hbm24797-bib-0014){ref-type="ref"}; Ellison‐Wright & Bullmore, [2009](#hbm24797-bib-0022){ref-type="ref"}; Haijma et al., [2013](#hbm24797-bib-0029){ref-type="ref"}). Among the various MRI techniques, resting‐state functional MRI (rsfMRI) has been widely applied and aberrant brain activity has been reported in schizophrenia patients (Cheng, Newman, et al., [2015](#hbm24797-bib-0013){ref-type="ref"}; Cheng, Palaniyappan, et al., [2015](#hbm24797-bib-0014){ref-type="ref"}; Tang et al., [2013](#hbm24797-bib-0062){ref-type="ref"}; Xu & Lipsky, [2014](#hbm24797-bib-0068){ref-type="ref"}).

However, results from traditional MRI studies are group‐level data and have limited clinical applications. More recently, machine learning has been increasingly utilized to optimize the use of brain imaging data in clinical classification and build predictive models for individualized diagnosis for different psychiatric disorders (Arbabshirani, Plis, Sui, & Calhoun, [2017](#hbm24797-bib-0006){ref-type="ref"}). Machine learning is defined as the process of enabling computers to acquire the ability to learn patterns of data without being explicitly programmed to do so (Samuel, [1959](#hbm24797-bib-0053){ref-type="ref"}). Multivariate machine learning approaches are algorithms specialized in recognizing patterns from high‐dimensional data like brain imaging data, which can capture the complex relationships between brain regions compared with univariate methods (Davatzikos, [2004](#hbm24797-bib-0020){ref-type="ref"}). The general machine learning framework with rsfMRI data for computational psychiatry includes: (a) preprocessing the imaging data; (b) separating the training data and the testing data completely; (c) extracting and selecting features from the training data; (d) training the predictive model; and (e) generalizing the predictive model to the testing data. In this framework, assessing generalizability is one of the most important steps in evaluating predictive models, which simulates the real‐world context. Generalizability is assessed in two distinct settings: within‐site and between‐site. Two main strategies, internal validation (or cross‐validation) and external validation, have been used to assess generalizability. Within‐site generalizability is typically established using cross‐validation. In this setting, a data set collected from a single site is repeatedly split into independent training and test data sets, and the performance of the model is assessed in the training set for each split. However, to assess between‐site generalizability, the predictive model is trained on a data set from one site and then applied to an independent data set collected in a separate site using external validation. Using internal validation is practical considering the difficulty in collecting data from different sites, but it could lead to an overestimation of performance due to overfitting of the predictive model to one specific data set, compared with external validation which considers generalizability across different data sets (Woo, Chang, Lindquist, & Wager, [2017](#hbm24797-bib-0067){ref-type="ref"}). It is therefore important to assess generalizability using both internal and external validation methods.

A number of promising studies have successfully classified patients with schizophrenia from healthy controls based on rsfMRI data using machine learning approaches. As shown in Table [1](#hbm24797-tbl-0001){ref-type="table"}, accumulated studies have utilized machine learning as a tool to analyze rsfMRI data, investigate the underlying neural mechanisms, recognize specific brain patterns, and classify patients with schizophrenia from healthy controls at the individual level with accuracies ranging from 65 to 95% (Arbabshirani, Kiehl, Pearlson, & Calhoun, [2013](#hbm24797-bib-0070){ref-type="ref"}; Cao et al., [2018](#hbm24797-bib-0071){ref-type="ref"}; Cheng, Newman, et al., [2015](#hbm24797-bib-0013){ref-type="ref"}; Cheng, Palaniyappan, et al., [2015](#hbm24797-bib-0014){ref-type="ref"}; Du et al., [2012](#hbm24797-bib-0021){ref-type="ref"}; Venkataraman et al., [2012](#hbm24797-bib-0064){ref-type="ref"}). However, most of these studies have only assessed generalizability using internal validation methods. While two studies have used external validation to assess the generalizability of their classification methods, they did so in independent rsfMRI data sets (Cui, Liu, Song, et al., [2018](#hbm24797-bib-0018){ref-type="ref"}; Cui, Liu, Wang, et al., [2018](#hbm24797-bib-0017){ref-type="ref"}; Skatun et al., [2017](#hbm24797-bib-0057){ref-type="ref"}) and no study has independently replicated the machine learning procedure from a previous study.

###### 

Summary of machine learning studies in schizophrenia based on rsfMRI

  Reference                                                                                                                                         Participants         Feature                                            Feature extraction                            Classifier                                 Accuracy (%)
  ------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- -------------------------------------------------- --------------------------------------------- ------------------------------------------ --------------
  Shen, Wang, Liu, and Hu ([2010](#hbm24797-bib-0056){ref-type="ref"})                                                                              SZ = 32, HC = 20     FC among 116 regions                               Correlation coefficient rank; LLE             C‐means clustering                         86.5
  Fan et al. ([2011](#hbm24797-bib-0024){ref-type="ref"})                                                                                           SZ = 31, HC = 31     Functional brain networks from ICA                 ICA, Grassmann manifold analysis              SVM                                        85.5
  Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"})                                                                                            SZ = 28, HC = 28     Spatial components from ICA                        *t* test; PCA; FLD                            Majority voting                            93
  Tang, Wang, Cao, and Tan ([2012](#hbm24797-bib-0063){ref-type="ref"})                                                                             SZ = 22, HC = 22     FC by 90 regions                                   Correlation coefficient rank; PCA             Linear SVM                                 93.2
  Bassett, Nelson, Mueller, Camchong, and Lim ([2012](#hbm24797-bib-0008){ref-type="ref"})                                                          SZ = 15, HC = 14     FC by the graph                                    No                                            Linear kernel SVM                          75
  Venkataraman, Whitford, Westin, Golland, and Kubicki ([2012](#hbm24797-bib-0064){ref-type="ref"})                                                 SZ = 18, HC = 18     FC by 77 ROIs                                      Select by prior knowledge and random forest   Majority voting                            75
  Anderson and Cohen ([2013](#hbm24797-bib-0003){ref-type="ref"})                                                                                   SZ = 72, HC = 74     FNC by the graph                                   ICA                                           SVM                                        65
  Arbabshirani et al. (2013)                                                                                                                        SZ = 28, HC = 28     FNC                                                ICA; visually inspect                         K‐nearest neighbors                        96
  Fekete et al. ([2013](#hbm24797-bib-0025){ref-type="ref"})                                                                                        SZ = 8, HC = 10      FNC by the graph                                   No                                            Multi kernel block diagonal optimization   100
  Su, Wang, Shen, Feng, and Hu ([2013](#hbm24797-bib-0058){ref-type="ref"})                                                                         SZ = 32, HC = 32     FC                                                 Correlation coefficient rank                  Linear kernel SVM                          81.2
  Watanabe, Kessler, Scott, Angstadt, and Sripada ([2014](#hbm24797-bib-0065){ref-type="ref"})                                                      SZ = 54, HC = 67     FC by 347 ROIs                                     Elastic‐net                                   SVM                                        73.5
  Cheng, Newman, et al. ([2015](#hbm24797-bib-0013){ref-type="ref"}) and Cheng, Palaniyappan, et al. ([2015](#hbm24797-bib-0014){ref-type="ref"})   SZ = 415, HC = 405   FC by BWAS                                         No                                            SVM                                        75.8
  Chyzhyk, Savio, and Grana ([2015](#hbm24797-bib-0016){ref-type="ref"})                                                                            SZ = 74, HC = 72     FC/ local activity                                 Pearson\'s correlation coefficient            SVM                                        91.2/100
  Savio and Grana ([2015](#hbm24797-bib-0054){ref-type="ref"})                                                                                      SZ = 72, HC = 74     ALFF, fALFF, VMHC, ReHo                            Voxel site saliency measures                  SVM; RF                                    80
  Cheng, Newman, et al. ([2015](#hbm24797-bib-0013){ref-type="ref"}) and Cheng, Palaniyappan, et al. ([2015](#hbm24797-bib-0014){ref-type="ref"})   SZ = 27, HC = 36     BC of FC                                           Rank BC                                       SVM                                        79
  Kaufmann et al. ([2015](#hbm24797-bib-0034){ref-type="ref"})                                                                                      SZ = 71, HC = 196    FC from ICA                                        No                                            Regularized LDA                            84.4
  Kim et al. ([2016](#hbm24797-bib-0073){ref-type="ref"})                                                                                           SZ = 50, HC = 50     FC among 116 regions                               No                                            Deep neural network                        86
  Skatun et al. ([2017](#hbm24797-bib-0057){ref-type="ref"})                                                                                        SZ = 182, HC = 348   FC from ICA                                        No                                            Regularized LDA                            78.3
  Cui, Liu, Song, et al. ([2018](#hbm24797-bib-0018){ref-type="ref"}) and Cui, Liu, Wang, et al. ([2018](#hbm24797-bib-0017){ref-type="ref"})       SZ = 108, HC = 121   FC by 90 ROIs                                      Two sample *t* tests, LASSO                   SVM                                        82.6
  Cao et al. (2018)                                                                                                                                 SZ = 43, HC = 29     MI and FC between STC and other cortical regions   Top 10 features                               SVM                                        78.6

Abbreviations: BC, betweenness centrality; BWAS, brain‐wide association study; FLD, Fisher linear discriminant; FNC, functional network connectivity; HC, healthy controls; LASSO, least absolute shrinkage and selection operator; LDA, linear discriminative analysis; LLE, locally linear embedding; MI, mutual information; PCA, principle component analysis; RF, random forest; ROI, region of interest; STC, superior temporal cortex; SZ, patients with schizophrenia; VMHC, voxel‐mirrored homotopic connectivity.

In this study, the overall aim was to assess the within‐site and between‐site generalizability of a previous machine learning framework of rsfMRI data that have shown promising performance using both internal and external validation methods. Among the various previous studies, Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}) have reported an excellent classification accuracy of 0.93 using rsfMRI data and 0.98 using fMRI data in identifying schizophrenia patients from healthy controls based on their own machine learning procedure. Therefore, we examined the generalizability of this machine learning procedure in the present study. We first investigated the generalizability of the classification procedure in a main data set from a single site (internal validation) following the exact steps from Du et al.\'s study. Then, we assessed the between‐site generalizability to a completely independent data set (validated data set) from a different site (external validation) to test whether factors from different sites, such as scanning setting and procedure, would influence generalizability. To further explore the generalizability of the procedure rather than the algorithm itself, we updated the unsupervised part of the algorithm to investigate the degree to which the performance of between‐site generalizability could be improved in the new setting. Importantly, the labels (schizophrenia or healthy control) of the testing data set were not used when training the predictive model in the last step, which served to determine the between‐site generalizability of the procedure from independent data sets. Given the excellent performance of the procedure reported by Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}), we hypothesized that this machine learning procedure could discriminate patients with schizophrenia from healthy controls with promising classification performance with good within‐site generalizability. Due to the effect of site on rsfMRI data (Dansereau et al., [2017](#hbm24797-bib-0019){ref-type="ref"}), we further hypothesized that the cross‐site generalizability of the procedure would be compromised. Moreover, because some site effects could be taken into account when updating the unsupervised last step of the procedure, we further hypothesized that the between‐site generalizability would improve in the new setting.

2. METHODS {#hbm24797-sec-0002}
==========

2.1. Participants {#hbm24797-sec-0003}
-----------------

Two data sets of patients with schizophrenia and healthy controls were included in this study. In the main data set, 51 patients with schizophrenia and 51 healthy controls were recruited (Table [2](#hbm24797-tbl-0002){ref-type="table"}). Schizophrenia patients were recruited from the Community Health Service Centre of the Institute of Mental Health (the sixth Affiliated Hospital of Peking University) in the Haidian District of Beijing, China. In the validated data set, 34 patients with schizophrenia and 27 healthy controls were recruited (Table [2](#hbm24797-tbl-0002){ref-type="table"}). The patients with schizophrenia were recruited from the Changsha Psychiatric Hospital, Changsha, Hunan province, China. The diagnosis of schizophrenia was ascertained with the Structural Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV), Fourth Edition (Frances, 1994). The Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, [1987](#hbm24797-bib-0035){ref-type="ref"}) was used to assess the severity of schizophrenia symptoms. Both the clinical assessment and the diagnostic interviews were conducted by experienced psychiatrists. All patients were taking antipsychotic medications. Healthy controls were recruited from the local community via advertisements. They had no personal and family history of mental disorders. Participants with neurological disorders, substance abuse, and/or dependence or head injuries were excluded. The short form of the Chinese version of the Wechsler Adult Intelligence Scale (Gong, [1992](#hbm24797-bib-0028){ref-type="ref"}) was used to estimate the IQ of all participants.

###### 

Demographic and clinical information of two data sets

                             HC                SZ                 *t*/χ ^2^   *p*
  -------------------------- ----------------- ------------------ ----------- ------
  The main data set                                                           
  Demographics                                                                
  Age (years)                42.04 (12.165)    43.22 (10.885)     −.515       .608
  Gender (male%)             35.29%            41.18%             .374        .684
  Education (years)          12.80 (3.731)     12.07 (2.946)      1.105       .272
  Estimated IQ\*             119.76 (11.735)   107.68 (14.215)    4.663       .000
  Clinical characteristics                                                    
  Onset age (years)                            25.41 (9.185)                  
  Course (years)                               16.66 (8.067)                  
  PANSS total                                  51.69 (14.771)                 
  PANSS positive                               11.63 (4.858)                  
  PANSS negative                               13.39 (5.783)                  
  PANSS general                                26.67 (7.618)                  
  CPZ equivalent dose (mg)                     236.56 (172.208)               
  The validated data set                                                      
  Demographics                                                                
  Age\* (years)              27.37 (7.344)     36.5 (7.140)       −4.898      .000
  Gender\* (male%)           44.44%            82.35%             9.580       .003
  Education\* (years)        13.93 (2.814)     12.18 (2.208)      2.722       .009
  Estimated IQ               108.00 (20.196)   93.94 (24.799)     1.970       .055
  Clinical characteristics                                                    
  Onset age (years)                            24.17 (6.644)                  
  Course (years)                               10.54 (7.868)                  
  PANSS total                                  67.72 (12.378)                 
  PANSS positive                               10.00 (3.873)                  
  PANSS negative                               23.16 (3.118)                  
  PANSS general                                30.84 (7.238)                  
  CPZ equivalent dose (mg)                     287.05 (193.830)               

*Note*. Table values: mean (*SD*).

Abbreviations: CPZ: chlorpromazine; HC, healthy controls; PANSS, the Positive and Negative Syndrome Scale; SZ, patients with schizophrenia.

\**p* \< 0.05.

In addition, independent sample *t* tests were conducted to compare age, length of education and estimated IQ between the two healthy control groups (Table [3](#hbm24797-tbl-0003){ref-type="table"}), and the same were conducted to compare onset age, duration of illness and severity of psychotic symptoms between the two patient groups. Chi‐square tests were also used to compare the gender proportion between the two healthy control groups and the two clinical groups. Finally, a five‐factor model of the PANSS (Anderson et al., [2017](#hbm24797-bib-0004){ref-type="ref"}; Lindenmayer, Grochowski, & Hyman, [1995](#hbm24797-bib-0039){ref-type="ref"}) comprising negative, positive, disorganized, excited, and anxiety symptom domains was computed and compared between the two clinical groups (Table [3](#hbm24797-tbl-0003){ref-type="table"}).

###### 

Comparison of demographic and clinical information between two sites

                             SZ                 HC                                                                             
  -------------------------- ------------------ ------------------ -------- ------ ----------------- ----------------- ------- ------
  Demographics                                                                                                                 
  Age (years)                43.22 (10.885)     36.50 (7.14)       3.168    .002   42.04 (12.165)    43.22 (10.885)    −.515   .608
  Gender (male%)             41.18%             82.35%             14.167   .000   35.29%            44.44%            .625    .470
  Education (years)          12.07 (2.946)      12.18 (2.208)      −.182    .856   12.80 (3.731)     12.07 (2.946)     1.105   .272
  Estimated IQ               107.68 (14.215)    93.94 (24.799)     3.206    .002   119.76 (11.735)   107.68 (14.215)   4.663   .000
  Clinical characteristics                                                                                                     
  Onset age (years)          25.41 (9.185)      24.17 (6.644)      .594     .554                                               
  Course (years)             16.66 (8.067)      10.54 (7.868)      3.070    .003                                               
  PANSS total                51.69 (14.771)     67.72 (12.378)     −4.678   .000                                               
  PANSS positive             11.63 (4.858)      10.00 (3.873)      1.461    .148                                               
  PANSS negative             13.39 (5.783)      23.16 (3.118)      −7.884   .000                                               
  PANSS general              26.67 (7.618)      30.84 (7.238)      −2.28    .025                                               
  CPZ equivalent dose (mg)   236.56 (172.208)   287.05 (193.830)   −1.024   .310                                               
  PANSS~5~ negative          15.20 (6.636)      28.17 (4.428)      −8.544   .000                                               
  PANSS~5~ positive          10.47 (4.888)      8.17 (2.973)       2.127    .037                                               
  PANSS~5~ disorganized      15.22 (4.500)      17.09 (4.067)      −1.704   .093                                               
  PANSS~5~ excited           5.61 (2.155)       5.92 (2.701)       −.533    .596                                               
  PANSS~5~ anxiety           8.75 (3.918)       8.76 (3.358)       −.016    .987                                               

*Note*. Table values: mean (*SD*).

Abbreviations: CPZ, chlorpromazine; HC, healthy controls; main, main data set; PANSS, the Positive and Negative Syndrome Scale; PANSS~5~, the symptom domains calculated by the five‐factor model; SZ, patients with schizophrenia; validated: validated data set.

The study was approved by the Ethics Committee of the Institute of Psychology, the Chinese Academy of Sciences. All participants gave written informed consent.

2.2. Image acquisition {#hbm24797-sec-0004}
----------------------

For the main data set, all participants were scanned in a 3‐T Siemens Tim Trio scanner at the Chaoyang Hospital, Beijing, China. The rsfMRI data were collected by an echo‐planar imaging (EPI) sequence utilizing gradient echo. Slices were acquired in interleaved order and the data consisted of 200 whole‐brain volumes (repetition time (TR) = 2,500 ms, echo time (TE) = 21 ms, flip angle = 90°, slice number = 42, slice thickness = 3.5 mm, matrix size = 64 × 64, field of view (FOV) = 200 mm, and voxel size = 3.1 × 3.1 × 3.5 mm^3^). T1‐weighted structural image data were collected for anatomical reference using a 3D magnetization‐prepared rapid gradient‐echo (MPRAGE) sequence (TR = 2,530 ms, TE = 2.34 ms, flip angle = 7°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm^3^).

For the validated data set, all participants were scanned in a 3‐T Siemens TIM Trio scanner in the Hunan Provincial People\'s Hospital, Changsha, Hunan province, China. The rsfMRI data were collected by an EPI sequence utilizing gradient echo. Slices were acquired in interleaved order and the data consisted of 180 whole‐brain volumes (TR = 2,000 ms, TE = 25 ms, flip angle = 80°, slice number = 32, slice thickness = 4.5 mm, matrix size = 64 × 64, FOV = 240 mm, and voxel size = 3.75 × 3.75 × 4.5 mm^3^). T1‐weighted structural image data were collected using a 3D MPRAGE sequence (TR = 2,000 ms, TE = 2.26 ms, flip angle = 8°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm^3^).

While participants were in the scanner, they were asked to remain as stationary as possible and their heads were stabilized with foam pads.

2.3. Data preprocessing {#hbm24797-sec-0005}
-----------------------

Image preprocessing was conducted with the Statistical Parameter Mapping (SPM) software (SPM12; <http://www.fil.ion.ucl.ac.uk/spm/software/spm12>), Data Processing Assistant for Resting‐State fMRI (DPARSF) Software (DPARSF4.3; <http://rfmri.org/DPARSF>), and a plugin‐in for SPM named Temporal Filter (<http://www.brain-fmri.com/tempfilter>) (Madsen, Krohne, Cai, Wang, & Chan, [2018](#hbm24797-bib-0040){ref-type="ref"}). The two data sets were preprocessed separately with the same steps. To avoid T1 relaxation effects prior to equilibrium, the first five volumes of each resting state scan were excluded. Then, the remaining volumes for each of the functional imaging sessions were processed using DPARSF, including slice timing, realignment, and coregistration to the structural images. Mean frame‐wise displacement (FD) was calculated (Power, Barnes, Snyder, Schlaggar, & Petersen, [2012](#hbm24797-bib-0051){ref-type="ref"}) for each participant. The percentage of time points with mean FD power \>0.5 was lower than 10% for all participants. In order to remove nonstationary signals and other artifacts, the temporal filter toolbox (Madsen et al., [2018](#hbm24797-bib-0040){ref-type="ref"}) was used. Processing steps included: despiking (Patel et al., [2014](#hbm24797-bib-0048){ref-type="ref"}), high‐pass filtering and removal of low‐frequency drifts and motion by a 24‐parameter autoregressive model using realignment regressors and scrubbing (using a 1 mm relative movement threshold and a 1% DVARS threshold (Power et al., [2012](#hbm24797-bib-0051){ref-type="ref"})) (Friston, Williams, Howard, Frackowiak, & Turner, [1996](#hbm24797-bib-0026){ref-type="ref"}). Subsequently, spatial normalization with DARTEL was adopted to normalize the functional images into Montreal Neurological Institute (MNI) space (Ashburner, [2009](#hbm24797-bib-0007){ref-type="ref"}) in SPM12. Finally, an 8‐mm full‐width‐at‐half‐maximum isotropic Gaussian kernel was used to smooth the functional images (Table [5](#hbm24797-tbl-0005){ref-type="table"}).

###### 

Selected spatial components used for classification

  Index    Component name             Spatial location                                                                 Peak MNI region                    Peak MNI coordinates (mm)
  -------- -------------------------- -------------------------------------------------------------------------------- ---------------------------------- ---------------------------
  \(1\)    Occipital lateral cortex   Left calcarine sulcus + left middle occipital gyrus + lingual gyrus              Left calcarine sulcus              −12, −93, −3
  \(2\)    Occipital medial cortex    Calcarine                                                                        Left calcarine sulcus              0, −75, 9
  \(3\)    Cerebellum                 Left lobule VIII, left crus I, and lobule VI of cerebellar hemisphere            Lobule IX of vermis                3, −60, −39
  \(4\)    Fusiform                   Fusiform gyrus + lingual gyrus                                                   Right lingual gyrus                24, −60, −9
  \(5\)    Basal ganglia              Putamen + thalamus + caudate nucleus                                             Left putamen                       −21, 9, −3
  \(6\)    Precentral gyrus           Precentral gyrus + left postcentral gyrus                                        Left postcentral gyrus             −51, −9, 33
  \(7\)    Anterior DMN               Anterior cingulate gyrus + left medial frontal gyrus                             Left medial orbitofrontal cortex   0, 51, −3
  \(8\)    Temporal lobe              Middle temporal gyrus + right superior temporal gyrus                            Right superior temporal gyrus      60, −42, 12
  \(9\)    Posterior DMN              Precentral gyrus + left cuneus                                                   Left precuneus                     0, −69, 36
  \(10\)   Middle cingulate           Midcingulate area                                                                Left midcingulate area             0, −33, 45
  \(11\)   Occipital medial cortex    Middle occipital gyrus + cuneus + superior occipital gyrus                       Right middle occipital gyrus       30, −81, 24
  \(12\)   Frontal superior cortex    Superior frontal gyrus + right supplementary motor area + middle frontal gyrus   Left supplementary motor area      0, 6, 60
  \(13\)   DMN                        Medial frontal gyrus                                                             Left medial frontal gyrus          0, 51, 33
  \(14\)   Central gyrus              Postcentral gyrus + precentral gyrus                                             Undefined                          0, −27, 66
  \(15\)   DMN                        Middle frontal gyrus + superior frontal gyrus                                    Right midcingulate area            3, 24, 36
  \(16\)   Precuneus                  Precentral gyrus + superior parietal lobule                                      Left precuneus                     0, −57, 54

2.4. Machine learning analysis {#hbm24797-sec-0006}
------------------------------

After preprocessing, further machine learning analysis was conducted (see Figure [1](#hbm24797-fig-0001){ref-type="fig"} for the analysis flowchart). To assess generalizability by internal validation, we followed the procedures from Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}) in the main data set. To assess between‐site generalizability by external validation, the predictive model built in the main data set was directly applied to the validated data set. To establish transfer learning and to explore factors influencing between‐site generalizability, the unsupervised group independent component analysis (ICA) step was updated based on the two data sets and the between‐site generalizability was estimated again. In general, the machine learning framework consisted of the following steps: (a) extracting and selecting the spatial components (features) for all participants; (b) identification of features with significant differences using a two‐sample *t* test with thresholding; (c) kernel principal component analysis (PCA); (d) Fisher linear discriminant (FLD) analysis on individual components; and (e) majority voting across components.

![The flowchart shows machine learning procedures through internal and external validation. FLD, Fisher linear discrimination; GICA, group independent component analysis; PCA, principle component analysis; STR, spatial--temporal reconstruction](HBM-41-172-g001){#hbm24797-fig-0001}

### 2.4.1. Assessing within‐site generalizability {#hbm24797-sec-0007}

In feature extraction and selection, spatial group ICA was first run based on the entire main data set. Data for all participants were concatenated across time. Then, PCA was used to reduce the data into 40 principal components at the participant level. Afterward, ICA was performed to extract 30 independent spatial components based on the resulting data from the PCA at the group level. The analysis of spatial group ICA employed Infomax ICA (Bell & Sejnowski, [1995](#hbm24797-bib-0009){ref-type="ref"}) in the GIFT software package for MATLAB (GIFT, 2011). Second, the 16 spatial components were selected manually according to the exclusion criteria below:Components originating from artifacts, motion, and respiratory/cardiac cycles, which were identified by considering how much regions known to be associated with these signals were represented in the components. This included edges (motion, respiration), major arteries or veins, the circle of Willis, and the sagittal sinus (cardiac cycle) as well as regions in the vicinity of field inhomogeneity (movement by field inhomogeneity interaction effects).Components consisting of ventricles.Components that showed low and widespread activation.

This step provided a template of spatial components to establish correspondence of components in the subsequent LOO ICA analysis. Then, LOO cross‐validation was used to separate the data into a test set (one participant) and a training set (the remaining sample) and group ICA was performed for the training data. In order to identify individual subject components, spatial--temporal reconstruction (Nickerson, Smith, Öngür, & Beckmann, [2017](#hbm24797-bib-0044){ref-type="ref"}) based on the ICA model was used to obtain the spatial components for each participant in both the test and training data. A matching procedure based on correlation with the template of spatial components was used to establish component correspondence between the LOO splits. Then, a voxel‐wise two‐sample *t* test between the two groups for the training data was conducted to order the voxel in terms of their *t*‐test value/significance to obtain maximally discriminative features. Only voxels with *t* values larger than a threshold *t* ~0~ proceeded to the next step. The threshold *t* ~0~ was determined such that the class separation in the final FLD step was maximal within the training data set. When the final threshold value (*t* ~0~) was determined, the threshold was applied to the test data. Subsequently, the spatial components for the test and training data were decomposed by kernel PCA. Finally, the test and training data were projected to one dimension by Fisher\'s linear discriminant analysis (LDA) to make a final prediction of the test label.

After feature extraction and selection, classification was done for each of the 16 components independently and then combined by majority voting to make a final decision on the classification of each test sample. The classification procedure in Du et al.\'s ([2012](#hbm24797-bib-0021){ref-type="ref"}) study also reported the classification rates for combinations of components that achieved a high accuracy. However, as this selection procedure might lead to biased classification rates, we only considered classification results based on majority voting across all selected components in the present study.

### 2.4.2. Assessing between‐site generalizability {#hbm24797-sec-0008}

To assess between‐site generalizability by external validation, the template of spatial components which was used to select features in assessing within‐site generalizability was applied to the validated set of rsfMRI data. The spatial components for each participant in the validated data set were obtained through spatial--temporal reconstruction based on the template which was built from the main data set. In this setting, determination of the threshold *t* ~0~, kernel PCA and training of the LDA classifier considered only the main data set (training set), and hence the identified classification model was directly applied to the validated data set without any adaptation. Apart from changing the LOO cross‐validation to cross‐sample validation, all classification parameters and procedures remained identical.

To further explore factors influencing between‐site generalizability, we updated the ICA step to consider data from both sites. To achieve this, we identified 30 spatially independent components across both data sets using group ICA and established correspondence to the template components from the within‐site generalization procedure using spatial correlation. The matching procedure involved calculating the pairwise spatial correlation between all 30 estimated components and the 16 template components. Then, pairs of components that exhibited the highest absolute correlation were sequentially matched to identify all 16 components in the joint data set. After this matching procedure, the components were visually inspected to confirm that they represented the same brain regions as the template. Importantly, in this setting, the validated data set was only considered in the training of the group ICA model and hence no label information from the validated data set was used in feature extraction or fitting of the classification model. Apart from the different templates of spatial components, the classification procedure was identical to the within‐site generalization setting. The significance of the classification performance was assessed using a random permutation test in all settings where an empirical null distribution was obtained by applying an identical classification procedure to the data with permutated class labels.

3. RESULTS {#hbm24797-sec-0009}
==========

3.1. Group ICA on the main rsfMRI data set {#hbm24797-sec-0010}
------------------------------------------

Based on the aforementioned criteria, 16 components were selected to classify patients with schizophrenia from healthy controls in the analysis. The selected components are shown in Figure [2](#hbm24797-fig-0002){ref-type="fig"}. The name, spatial location, peak MNI region, and peak MNI coordinates for each component are shown in Table [5](#hbm24797-tbl-0005){ref-type="table"}.

![Three orthogonal slices from selected components are shown in the figure. The mean components were calculated across all participants and converted into Z‐scores. Orthogonal projects are reproduced according to neurological convention](HBM-41-172-g002){#hbm24797-fig-0002}

###### 

Classification performance for each component

  Ind     Area                       Validation type   Acc     Sens    Spec    Ind      Area                      Validation type   Acc     Sens    Spec
  ------- -------------------------- ----------------- ------- ------- ------- -------- ------------------------- ----------------- ------- ------- -------
  \(1\)   Occipital lateral cortex   Internal          0.686   0.588   0.784   \(9\)    Posterior DMN             Internal          0.441   0.392   0.490
                                     External~1~       0.417   0.485   0.333                                      External~1~       0.450   0.424   0.481
                                     External~2~       0.450   0.333   0.593                                      External~2~       0.583   0.485   0.704
  \(2\)   Occipital medial cortex    Internal          0.578   0.510   0.647   \(10\)   Middle cingulate          Internal          0.686   0.510   0.863
                                     External~1~       0.533   0.455   0.630                                      External~1~       0.433   0.152   0.778
                                     External~2~       0.583   0.515   0.667                                      External~2~       0.617   0.636   0.593
  \(3\)   Cerebellum                 Internal          0.598   0.392   0.804   \(11\)   Occipital medial cortex   Internal          0.588   0.353   0.824
                                     External~1~       0.417   0.333   0.519                                      External~1~       0.550   0.333   0.815
                                     External~2~       0.517   0.333   0.741                                      External~2~       0.550   0.697   0.370
  \(4\)   Fusiform                   Internal          0.657   0.490   0.824   \(12\)   Frontal superior cortex   Internal          0.529   0.627   0.431
                                     External~1~       0.567   0.364   0.815                                      External~1~       0.550   0.727   0.333
                                     External~2~       0.467   0.242   0.741                                      External~2~       0.533   0.576   0.481
  \(5\)   Basal ganglia              Internal          0.706   0.627   0.784   \(13\)   DMN                       Internal          0.647   0.490   0.804
                                     External~1~       0.500   0.242   0.815                                      External~1~       0.483   0.303   0.704
                                     External~2~       0.667   0.606   0.741                                      External~2~       0.617   0.576   0.667
  \(6\)   Precentral gyrus           Internal          0.578   0.686   0.471   \(14\)   Central gyrus             Internal          0.627   0.431   0.824
                                     External~1~       0.500   0.576   0.407                                      External~1~       0.617   0.485   0.778
                                     External~2~       0.633   0.576   0.704                                      External~2~       0.483   0.242   0.778
  \(7\)   Anterior DMN               Internal          0.618   0.510   0.725   \(15\)   DMN                       Internal          0.431   0.353   0.510
                                     External~1~       0.600   0.545   0.667                                      External~1~       0.583   0.606   0.556
                                     External~2~       0.550   0.788   0.259                                      External~2~       0.650   0.606   0.704
  \(8\)   Temporal lobe              Internal          0.657   0.667   0.647   \(16\)   Precuneus                 Internal          0.676   0.647   0.706
                                     External~1~       0.550   0.333   0.815                                      External~1~       0.550   0.455   0.667
                                     External~2~       0.667   0.788   0.519                                      External~2~       0.583   0.333   0.889

*Note*. Ind, index; Acc, accuracy; Sens, sensitivity; Spec, specificity; Internal, internal validation within the main data set; External~1~, external validation generalizing to the validated data set from the main data set by the template based on the main data set; External~2~, external validation generalizing to the validated data set from the main data set by the template based on both data set.

3.2. Within‐site classification performance {#hbm24797-sec-0011}
-------------------------------------------

For classification based on individual features, the performances including accuracy, sensitivity, and specificity of each component are shown in Table [5](#hbm24797-tbl-0005){ref-type="table"}. We found that the basal ganglia (the fifth feature) achieved the highest accuracy (0.706). The occipital lateral cortex (the first feature), the fusiform gyrus (the fourth feature), the temporal lobe (the eighth feature), the middle cingulate gyrus (the 10th feature), and the precuneus (the 16th feature) achieved a similar accuracy. However, the accuracy of the posterior DMN (the ninth feature) and the DMN (the 15th feature) was lower than random chance. The sensitivity across all features was close to or lower than 0.5, while the specificity across all features was close to or higher than 0.5. When combining all 16 features, majority voting achieved a classification accuracy of 0.725, a sensitivity of 0.569, and a specificity of 0.882.

3.3. Between‐site classification performance {#hbm24797-sec-0012}
--------------------------------------------

Between‐site generalizability was assessed using the template of spatial components from the main data set. We found that accuracy in general decreased to the random level for classification from each selected component (see Table [4](#hbm24797-tbl-0004){ref-type="table"} and Figure [3](#hbm24797-fig-0003){ref-type="fig"}). When all 16 features were combined by majority voting, the performance was worse compared to the within‐site performance evaluated by internal validation, with an accuracy of 0.550, a sensitivity of 0.394 and a specificity of 0.741. Random permutation test showed that the accuracy failed to reach statistical significance, with a *p* value of .183.

![Accuracy, sensitivity, and specificity based on individual features. Internal validation was conducted within the main data set, external validation~1~ was conducted by directly applying the classification procedure from the main data set to the validated data set, and external validation~2~ was conducted using an updated group ICA across both data sets but with all other steps being identical](HBM-41-172-g003){#hbm24797-fig-0003}

For the between‐site generalizability by external validation using ICA across both data sets, we found that the performance was similar to the within‐site classification performance for each selected component (see Table [5](#hbm24797-tbl-0005){ref-type="table"} and Figure [3](#hbm24797-fig-0003){ref-type="fig"}). When all 16 features were combined by majority voting, the performance remained similar to the first classification, with an accuracy of 0.700, a sensitivity of 0.636 and a specificity of 0.778. Random permutation test revealed that the accuracy was statistically significant, with a *p* value of .0005.

4. DISCUSSION {#hbm24797-sec-0013}
=============

4.1. Classification performance compared with the previous study through LOO {#hbm24797-sec-0014}
----------------------------------------------------------------------------

In this study, we first followed a machine learning procedure developed by Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}) using rsfMRI data from a sample of schizophrenia patients and healthy controls to assess the within‐site generalizability and the reproducibility of the machine learning procedure. The classification followed the same feature extraction, feature selection, and LOO validation steps as Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}). We found that based on individual features, the highest classification accuracy was 0.706, while the classification accuracy was 0.725 when all selected components were combined. To establish correspondence with Du et al.\'s ([2012](#hbm24797-bib-0021){ref-type="ref"}) study, the performance of individual components can be found in Table [5](#hbm24797-tbl-0005){ref-type="table"}. Since testing individual components or combinations of those would result in multiple comparisons and the classification results using individual components were less stable than the result from majority voting, we focused on the results obtained from majority voting across all 16 components to avoid overinterpretation. Although the accuracy in the present study is not as high as the results from Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}), compared with the overall reported accuracy of 65--95% in the field (Anderson & Cohen, [2013](#hbm24797-bib-0003){ref-type="ref"}; Bassett et al., [2012](#hbm24797-bib-0008){ref-type="ref"}; Fan et al., [2011](#hbm24797-bib-0024){ref-type="ref"}; Su et al., [2013](#hbm24797-bib-0058){ref-type="ref"}; Venkataraman et al., [2012](#hbm24797-bib-0064){ref-type="ref"}), our results support the reproducibility of the machine learning procedure which can successfully discriminate patients with schizophrenia from healthy controls.

Several factors may explain the reduced within‐site generalizability we found. First, 51 pairs of participants were recruited for LOO validation in our study, but Du et al.\'s study only had 28 pairs. The smaller sample size in Du et al.\'s study in the context of analyzing high‐dimensional imaging data could easily lead to overfitting of the predictive model to their data set (Mwangi, Tian, & Soares, [2014](#hbm24797-bib-0042){ref-type="ref"}). Second, the longer illness duration and lower symptom severity of our patients might have introduced more heterogeneity into the profile of participants (an der Heiden & Hafner, [2000](#hbm24797-bib-0002){ref-type="ref"}; Irani, Kalkstein, Moberg, & Moberg, [2011](#hbm24797-bib-0031){ref-type="ref"}), making it more difficult to identify patterns that are directly related to the disorder in question. Finally, although comprehensive preprocessing was performed to reduce noise and limit the effect of artifacts on the analysis (Churchill et al., [2011](#hbm24797-bib-0015){ref-type="ref"}), these confounding factors could still persist and could affect the classification performance.

4.2. Implication of between‐site generalizability {#hbm24797-sec-0015}
-------------------------------------------------

When assessing between‐site generalizability in two completely independent data sets from two sites, we obtained a nonsignificant accuracy of 0.550 and a significant accuracy of 0.700 based on all selected features when applying a template of spatial components built based on only the main data set and both data sets, respectively. It is important to note that although the validated data set was utilized with the main data set for generating a new template of spatial components through spatial group ICA, the labels of the validated data set were still kept unseen when training the model to ensure that the training and testing data sets were independent.

More importantly, the findings that the predictive model did not successfully generalize to the novel data set when applying the template only based on the training data set but successfully generalized to the independent testing data set when applying the template based on both data sets substantially extends our understanding of the generalizability of machine learning using rsfMRI data. Failure to generalize does not necessarily mean that a model is invalid, since multiple factors are different between independent data sets (Scheinost et al., [2019](#hbm24797-bib-0055){ref-type="ref"}). As indicated in Table [3](#hbm24797-tbl-0003){ref-type="table"}, the schizophrenia patients in the main data set were significantly older, had significantly higher estimated IQ, longer illness duration and higher PANSS positive subscale score, but significantly lower PANSS total, negative and general subscale scores compared with patients in the validated data set. In addition, the healthy controls in the main data set had significantly higher estimated IQ than the healthy controls in the validated data set. Such heterogeneity between the two data sets may be one potential factor contributing to the failure in direct generalization. In addition, the two data sets were acquired independently from different scanners with different acquisition parameters, which could further compromise generalizability. The differences in classification performance highlights the importance of considering differences in the new data when constructing classification models and demonstrates the usefulness of unsupervised transfer learning in this setting. Moreover, meta‐analytic studies of machine learning in schizophrenia have demonstrated that age, medication exposure, illness stage, and gender are all significant moderators of classification performance (Kambeitz et al., [2015](#hbm24797-bib-0033){ref-type="ref"}; Neuhaus & Popescu, [2018](#hbm24797-bib-0043){ref-type="ref"}).

Cui, Liu, Song, et al. ([2018](#hbm24797-bib-0018){ref-type="ref"}) and Cui, Liu, Wang, et al. ([2018](#hbm24797-bib-0017){ref-type="ref"}) evaluated the classification performance of their machine learning algorithm within the same data set and across different data sets and also found that the classification accuracy across different data sets was lower than within the same data set. However, the extent of difference in accuracy was not large in their study compared with ours. This could be due to differences in participant characteristics. In their study, patients with untreated first‐episode schizophrenia were recruited and the demographics were very similar between the two samples; whereas in our study, we recruited patients with chronic schizophrenia and the demographics were different between the two samples. Taken together, these findings suggest that future research to construct machine learning models should take into account illness heterogeneity.

4.3. Implication for schizophrenia research {#hbm24797-sec-0016}
-------------------------------------------

The classification performance based on individual features in this study revealed that the striatum yielded the highest accuracy. Spatial components including the lateral occipital cortex, the fusiform gyrus, the temporal lobe, the middle cingulate gyrus, the DMN, and the precuneus could also distinguish patients with schizophrenia from healthy controls with acceptable accuracy. These findings are supported by previous studies using machine learning methods in schizophrenia (Du et al., [2012](#hbm24797-bib-0021){ref-type="ref"}; Fan et al., [2011](#hbm24797-bib-0024){ref-type="ref"}; Savio & Grana, [2015](#hbm24797-bib-0054){ref-type="ref"}; Tang et al., [2012](#hbm24797-bib-0063){ref-type="ref"}; Yu et al., [2013](#hbm24797-bib-0069){ref-type="ref"}). Our findings suggest that the striatum may play a key role in schizophrenia. This is consistent with results from previous studies which demonstrated alteration in striatal volume (Chakravarty et al., [2015](#hbm24797-bib-0011){ref-type="ref"}) and white matter connectivity (James et al., [2016](#hbm24797-bib-0032){ref-type="ref"}). For the DMN, studies by Fan et al. ([2011](#hbm24797-bib-0024){ref-type="ref"}) and Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}) also suggest that it is one of the most informative brain regions for the diagnosis of schizophrenia. Moreover, a recent study found that the DMN interacted with the central executive network and the salience network in smoking schizophrenia patients, indicating the potential role of the DMN in the symptomatology of the disorder (Liao et al., [2018](#hbm24797-bib-0038){ref-type="ref"}). At the same time, the structural and functional alterations in the DMN in schizophrenia patients have been shown to be related to impairment in working memory and attention (Garrity et al., [2007](#hbm24797-bib-0027){ref-type="ref"}; Hu et al., [2017](#hbm24797-bib-0030){ref-type="ref"}; Pomarol‐Clotet et al., [2008](#hbm24797-bib-0049){ref-type="ref"}; Salgado‐Pineda et al., [2011](#hbm24797-bib-0052){ref-type="ref"}; Whitfield‐Gabrieli & Ford, [2012](#hbm24797-bib-0066){ref-type="ref"}). Previous studies have also suggested that the fusiform gyrus and the temporal lobe may be discriminative features for classification (Savio & Grana, [2015](#hbm24797-bib-0054){ref-type="ref"}; Tang et al., [2012](#hbm24797-bib-0063){ref-type="ref"}). In anatomical studies, reduced gray matter volume at the superior temporal gyrus has been reported in schizophrenia patients (Ohi et al., [2016](#hbm24797-bib-0045){ref-type="ref"}; Sun, Maller, Guo, & Fitzgerald, [2009](#hbm24797-bib-0059){ref-type="ref"}), which may also be related to hallucinations (Cui, Liu, Song, et al., [2018](#hbm24797-bib-0018){ref-type="ref"}; Cui, Liu, Wang, et al., [2018](#hbm24797-bib-0017){ref-type="ref"}).

4.4. Limitation {#hbm24797-sec-0017}
---------------

This study has several limitations. First, the sample size in the present study was small. Bigger data sets are needed to avoid overfitting and to build a classifier with better generalizability. Second, only one modality of data (rsfMRI) was utilized, even though both functional and structural brain information may be important for high‐accuracy classification using machine learning (Mikolas et al., [2017](#hbm24797-bib-0041){ref-type="ref"}; Orban et al., [2018](#hbm24797-bib-0046){ref-type="ref"}; Ota et al., [2012](#hbm24797-bib-0047){ref-type="ref"}). Third, we did not collect the smoking status of our participants in this study. Considering the high rate of smoking in schizophrenia patients (Liao et al., [2018](#hbm24797-bib-0038){ref-type="ref"}), which may influence brain activity (Potvin et al., [2016](#hbm24797-bib-0050){ref-type="ref"}; Tanabe, Tregellas, Martin, & Freedman, [2006](#hbm24797-bib-0060){ref-type="ref"}), smoking status may be a confounding factor that affects classification performance. Fourth, since our findings suggest the importance to take scanning setting and characteristics of participants into account when collecting data from different sites, future studies should examine how these two sets of factors affect between‐site generalizability.

5. CONCLUSION {#hbm24797-sec-0018}
=============

In this study, we found that the machine learning procedure developed by Du et al. ([2012](#hbm24797-bib-0021){ref-type="ref"}) could successfully classify patients with schizophrenia from healthy controls based on rsfMRI data in internal validation but not external validation. Moreover, we found that a transfer learning procedure based on unsupervised learning was able to improve between‐site generalizability and may eventually contribute to the incorporation of machine learning approaches into clinical practice.
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